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Abstract: Docosahexaenoic acid (DHA) potentially modulates inflammatory processes. Therefore, the aim of
this study was to determine the influence of DHA supplementation on the expression of intestinal inflammation
and nutritional status in rats which have undergone restorative proctocolectomy. Twenty-four Wistar rats were
operated. After the induction of pouchitis, animals were randomly divided into a control group (CG) and sup-
plementation groups receiving respectively a semi-synthetic diet without or with DHA (in a lower or higher
dose, respectively known as the lower dose, LD, and higher dose, HD, groups) for six weeks. Selected nutritional
parameters were assessed. Histopathological and immunohistochemical analysis of pouch mucosa specimens
was also performed. The effectiveness of feeding and quality of stools were significantly better in the HD group
than in the CG. The intensity of inflammation (Moskovitz scale) was higher in HD and LD than in CG (p = 0.03
and p = 0.0006, respectively). Nevertheless, pouch adaptation (Laumonier scale) was more significant in LD
than in CG (p = 0.007). On the other hand, tissue expression of IL-1a and IL-10 was higher in HD and LD than
in CG (IL-1a, p = 0.009 and p = 0.05, respectively; IL-10, p = 0.04 for both). DHA supplementation has no
impact on body weight gain. Yet it seems that it may improve the effectiveness of nutrition and stool quality in
rats which have undergone restorative proctocolectomy. Simultaneously, it increases the intensity of pouch
adaptation and inflammation. The specificity of observed changes is not clear. However, it may imply potential
modulation of inflammatory processes of pouch mucosa. (Folia Histochemica et Cytobiologica 2012; Vol 50,
No. 1, pp. 125–129)
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Introduction
Restorative proctocolectomy with ileal pouch-anal
anastomosis is a procedure consisting of excision of
the entire colon, creation of an ileal reservoir and
anastomosing it with preserved anal sphincters. The
major indications for proctocolectomy embrace ul-
cerative colitis (UC) and familial adenomatous poly-
posis (FAP) [1, 2]. As with any surgery, it implies the
possibility of postoperative complications, the com-
monest being pouchitis [3, 4]. According to the avail-
able data, it occurs in 5–60% of patients who under-
go surgery [4–6]. The diagnosis of pouchitis is based
on the Pouchitis Disease Activity Index (PDAI), which
combines clinical, endoscopic and histological crite-
ria (Moskowitz scale). For the evaluation of adaptive
changes, the Laumonier scale is used [7].
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Docosahexaenoic acid (DHA) belongs to the family
of n-3 long-chain polyunsaturated fatty acids (LCPUFA),
which de novo cannot be synthesized in humans [8, 9].
It is assumed that n-3 LCPUFAs exhibit anti-inflamma-
tory activity. Long-term consumption of DHA and eicos-
apentaenoic acid (EPA) may increase their tissue lev-
els, simultaneously decreasing the concentration of
arachidonic acid (AA). EPA and DHA replace AA in
tissue lipids, serum and thrombocyte membranes. As
a result, the synthesis of AA-derived eicosanoids decreas-
es, potentially inhibiting inflammation [8, 9].
Several controlled studies using dietary (in the
form of fish oil) patients with inflammatory bowel
disease (IBD) have been conducted [10–14]. Although
some trials have reported clinical improvement (e.g.
improved gut histology, decreased disease activity,
decreased use of corticosteroids, and decreased num-
ber of relapses), when these trials have been pooled,
no consistently strong clinical effect has emerged [8].
However, the selection of potential placebo was di-
verse, i.e. sunflower oil, corn oil, olive oil, short-chain
fatty acids and mixed oil. Moreover, the selection and
number of patients and duration of interventions also
differed. The results obtained in an animal model of
colitis were more homogenous and convincing. There
is no data on the effect of n-3 LCPUFA supplemen-
tation either in a human or an animal study.
Interestingly, it has been documented in the ani-
mal model of cystic fibrosis that DHA supplementa-
tion reduces inflammatory and destructive processes
in different organs, also in the small intestine. There-
fore in the present study we aimed to determine the
influence of pure DHA supplementation on the ex-
pression of rat intestinal inflammation, the effective-
ness of feeding, and the quality of stools in rats which
had undergone a restorative proctocolectomy.
Material and methods
After a seven day period of adaptation, and 24-hour fast-
ing, 24 animals underwent restorative proctocolectomy with
the creation of a J-pouch [15]. The strictured ileo-anal anas-
tomosis was performed intraoperatively. The stricture is one
of the causes of pouchitis both in clinical and experimental
models [16–18]. After one day of fasting (exclusive supply
of 8% glucose solution), the animals received a semi-syn-
thetic diet without fiber (AIN-93) in increasing doses for
ten days (respectively 5, 8, 10 and 12 g/d in the following
days, up to 25 g/d) [19]. Subsequently, the inflammation of
the J-pouch was induced in a model developed in our own
previous studies. For the following 11 days, the rats received
the same diet (up to 25 g/d). For that purpose over the next
seven days, all animals were administered feed AIN-93 sup-
plemented with fiber (in growing quantities, i.e. 1% on the
first day, 2% on the second, up to a maximum of 4% con-
tent). Subsequently, rats were allocated according to body
weight and then randomly divided into three equal sub-
groups (the control group and two supplementation groups).
Animals from the control group were fed ad libitum a semi-
synthetic diet AIN-93 for a period of six weeks. Rats from
the supplementation groups received the same diet enriched
with DHA (Laborest Italia SpA, Mediolan, Italy):
— at a dose of 500 mg/rat/day (additional vitamin E — as
an antioxidant agent according to Harris ratio — 0.010
g/kg of diet mass) in the high dose group (HD);
— at a dose of 250 mg/rat/day (additional vitamin E —
0.005 g/kg of diet mass) in the low dose group (LD).
Diets were prepared in a powdered form. The animals
had continuous access to food.
The quality of stools, body weight gains and energy in-
takes (based upon feed intake) were assessed every day
throughout the study. The effectiveness of feeding (ratio
between daily energy intake and daily weight gain) was also
calculated. All of the rats survived to the end of the study.
The animals were then euthanized, and specimens of
J-pouch mucosa for the histopathological and immunohis-
tochemical analysis were obtained.
All surgical procedures were conducted by one quali-
fied surgeon in accordance with the guidelines of the Euro-
pean Community Council directives 86/609/EEC and with
the approval of the Local Ethics Committee (42/2006).
Quality of stool. For the assessment of stool quality, a
5-point scale was used (1 — lack of stool, 2 — diarrhea, 3 —
blob of stool, 4 — textured stool, 5 — normal stool). Since
such an assessment was expected potentially to be subjec-
tive, the observer was ‘blinded’ to the animal group selec-
tion and the sample origin (MT).
Histopathological examination. Microscopic assessment was
performed according to standard histological techniques
(hematoxylin and eosin staining). In addition to routine his-
topathological examination, the collected specimens were
evaluated for the intensity of inflammation (Moskowitz
scale) and the adaptation changes with intestinal villous
shortening (Laumonier scale) [7].
Immunohistochemical examination. Tissue expression of
selected pro- (IL-1a, 6, 12) and anti-inflammatory (IL-10)
interleukins was evaluated using the ABC technique (Avi-
din–Biotin Complex) using a LSAB PLUS kit Kit/HRP
(DakoCytomation, Glostrup, Denmark) [20]. The color was
developed for 90 s using a Vector DAB substrate kit and
counterstained with Meyer’s hematoxylin (Vector Labora-
tories, Burlingame, CA, USA). The presence or absence of
cells with immunohistochemical reaction was assessed (as-
suming that honey-brown cytoplasm staining was equiva-
lent to a positive reaction) in a scale from 0 to 3 (+). The
interleukins were evaluated in epithelial cells and mononu-
clear inflammatory cells (macrophages and lymphocytes).
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Colonic histopathological preparations of patients with
active ulcerative colitis (UC) served as a positive control.
Those preparations in which during the immunohistochem-
ical staining the addition of a first antibody was omitted,
created a negative control. Immunohistochemical scoring
was determined by counting IL-1a, 6, 10, 12-immunore-
active cells on photomicrographs obtained from five ran-
dom high-power microscopic fields (400 × magnification).
Both histological and immunohistochemical assessment
was performed by a blinded histopathologist (PM).
Statistical analysis. For the parametric values, means and
standard deviations (SD) were calculated, while for the
nonparametric values, ranges were given. For both, medi-
ans were provided. Statistical analysis of data was performed
using the Kruskal–Wallis test with post-hoc comparisons.
Results
Body weight gains, energy intakes, the effectiveness of
feeding and the quality of stools during the supplemen-
tation period of the study are presented in Table 1. The
effectiveness of feeding was significantly better in HD
than in LD and CG. Moreover, the quality of stools
was significantly better in HD than in CG.
The severity of inflammation, expressed in the
Moskowitz scale, and the degree of pouch adapta-
tion, expressed in the Laumonier scale, are present-
ed in Table 2. The severity of inflammation was greater
in HD and LD than in CG. However, pouch adapta-
tion was more significant in LD than in CG.
Tissue expression of proinflammatory (IL-1a, IL-6
and IL-12) and anti-inflammatory (IL-10) interleukins
in pouch samples is summarized in Table 3. The ex-
pression of IL-6 and IL-12 was comparable in all ana-
lyzed groups. Nevertheless, tissue expression of IL-1a
and IL-10 was higher in HD and LD than in CG.
Discussion
The influence of nutritional modifications on the feed-
ing effectiveness and expression of pouchitis in rats which
have undergone a procedure of restorative proctocolec-
tomy was studied in the present study. The use of pure
DHA has been extrapolated from a mouse model of
cystic fibrosis (CF) in which it was demonstrated that
DHA supply leads to a decline of inflammatory and
destructive processes in the involved organs (lungs, pan-
creas and intestine) [21]. The choice of an adequate sup-
plementation dose was a difficult challenge. A CF mouse
model was taken as a reference, in which the DHA was
administered at a dose of 40 mg/day/mouse [22].
Restorative proctocolectomy implies the need for
entire large bowel resection. In humans, for around
three months, loop ileostomy is usually created, but
there is also a group of patients without ileostomy. In
Table 1. Body weight gains (BWG), energy intakes (EI), effectiveness of feeding (EF) and quality of stools (QS) during
the supplementation period of the study
Estimated HD LD CG p
parameter
Median (mean ± SD) Median (mean ± SD) Median (mean ± SD)
BWG [g/day] 2.5 1.8 1.8 NS
(2.5 ± 0.4) (1.9 ± 0.6) (1.9 ± 0.5)
EI [kcal] 96.7 95.4 99.1 NS
(96.4 ± 5.8) (95.4 ± 4.2) (98.5 ± 8.0)
EF [kcal/g] 37.9 50.6 53.9 HD vs. CG p = 0.01
(39.4 ± 4.9) (55.5 ± 21.1) (54.8 ± 14.4)
QS* 4 (3–5) 4 (3–5) 4 (2–5) HD vs. CG p = 0.004
*Median and range are given; HD — High dose group; LD — Low dose group; CG — Control group; NS — not significant
Table 2. Severity of inflammation (MS, Moskowitz scale) and degree of pouch adaptation (LS, Laumonier scale) during
the supplementation period of the study
Estimated HD LD CG Statistical significance
parameter
Median (range) Median (range) Median (range)
MS 5 (2–6) 5 (4–6) 2 (2–3) HD vs. CG p = 0.03
LD vs. CG p = 0.0006
LS 2 (1–3) 3 (2–4) 1 (1–2) LD vs. CG p = 0.007
HD — High dose group; LD — Low dose group; CG — Control group
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selected cases, the functional results for both types of
the procedure, i.e. with and without loop ileostomy,
are similar. In rats, a one-step procedure was done
and the ileostomy was omitted. Therefore, the pouch
was exposed to feces immediately after the procedure.
This resulted in severe diarrhea, which was observed in
animals for one week after the surgery. In the course of
the experiment, the consistency of stools improved un-
til they were formed, and sometimes were even normal.
Stool quality and the effectiveness of feeding were doc-
umented to be better in HD than CG. In the majority of
studies, such parameters are not recorded. Studies car-
ried out in UC patients suggest that n-3 LCPUFA sup-
plementation may lead not only to the decline of in-
flammation, but also to the reduction of disease activity
and the amelioration of symptoms [10, 11, 23]. In a cross-
over study, 11 UC patients received either a mixture of
n-3 PUFA (at a daily dose of 2.7 g EPA and 1.8 g DHA)
or a placebo i.e. corn oil (at a dose of 4.2 g/day). After
eight months of the nutritional modification, a 56% re-
duction of disease activity in the Truelove–Witts scale
was observed. In the mentioned scale, the quality of stool
(the presence of fresh blood and the number of diar-
rheal stools) was considered [23].
The intensity of inflammation was more severe in
DHA groups than in the control group which received
a regular diet of AIN-93. In some rats from the HD
and LD groups, it even reached the highest degree
(six points). These obtained results raise important
questions. Histopathological results suggested a wors-
ening course of the disease. However, clinical im-
provement may imply a more complicated situation.
The intensive pouchitis observed in the present study
in rats from the DHA groups may be the result of
massive modulation and reconstruction of the pouch,
which could be considered as a beneficial process [24].
This thesis was suggested by Vanderhoof et al, who
described the beneficial effect of a LCPUFA-enriched
diet, especially linolenic acid (n-3 family), with the
increased intensity of proliferation and modulation
of the jejunal mucosa epithelium [25].
Intestinal inflammation is activated by several fac-
tors e.g. pro-inflammatory cytokines.
In the present study, we saw higher IL-1 a activity in
pouch samples in DHA groups compared to the control
group. IL-1 a correlated with the intensity of pouchitis
using the Moskowitz scale. These results are not concor-
dant with available data. Medium enrichment with EPA
and DHA in cells cultures has resulted in inhibition of
production of IL-1b by monocytes and IL-6 by endot-
helial cells [26, 27]. It has been demonstrated in similar
human studies that n-3 acids supplementation (EPA +
+ DHA at doses above 2 g/day) in healthy volunteers
reduces IL-1 and IL-6 production [28, 29]. It should be
underlined that in compared studies, a mixture of n-3
fatty acids, and not pure DHA, was used. In addition,
only healthy subjects or cell cultures were assessed and
the dose of n-3 fatty acids was significantly lower.
IL-10 belongs to anti-inflammatory interleukins
[30]. In the present study, the expression of IL-10 was
statistically higher in DHA groups than in the control
group. Our data is concordant with the findings of Bra-
dley et al., who reported increased tissue activity of
IL-10 and its higher gene expression in adipocyte cell
cultures due to addition of DHA, unlike palmitic acid
and oleic acid [31]. The results obtained by Sierra et
al. suggest that the addition of EPA could have a more
significant effect than DHA. In that study, Balb/c mice
were fed with three different diets: standard (based on
sunflower oil), fish oil plus EPA-enriched (approxi-
mately 6.2 ± 0.9 mg/day), and fish oil plus DHA-en-
riched (approximately 8.4 ± 1.8 mg/day) [32]. After
three weeks of the supplementation, IL-10 concentra-
tions in macrophages and lymphocytes in the group of
animals supplemented with fish oil enriched in DHA
were lower than in the group receiving a diet with fish
oil enriched in EPA. However, a mixture of fatty acids
(fish oil), and not pure DHA was used in this study.
In conclusion, DHA supplementation has no impact
on body weight gain. Yet it seems that it may improve
the effectiveness of nutrition and stool quality in rats
which have undergone restorative proctocolectomy. Si-
multaneously, it increases the intensity of pouch adap-
tation and inflammation. The specificity of observed
changes is not clear. However, it may imply potential
modulation of inflammatory processes of pouch mucosa.
Table 3. Tissue expression of proinflammatory and anti-inflammatory interleukins in pouch samples
Estimated HD LD CG Statistical significance
parameter
Median (range) Median (range) Median (range)
IL-1a 2 (1–3) 2 (1–2) 1 (1–1) HD vs. CG p = 0.009
LD vs. CG p = 0.05
IL-6 1 (1–3) 2 (1–3) 1 (1–1) NS
IL-12 2 (1–3) 2.5 (1–3) 1 (1–2) NS
IL-10 3 (2–3) 3 (2–3) 2 (1–2) HD vs. CG p = 0.04
LD vs. CG p = 0.04
HD — High dose group; LD — Low dose group; CG — Control group; NS — not significant
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